The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conductedwithin long-term care and residential facilities that will test a communication andengagement strategy for increasing COVID-19 booster vaccination rates against an enhancedusual care comparator (Centers for Disease Control and Prevention or other nationalorganization vaccine education and communication materials) among facility staff. Thecommunication and engagement strategy being tested includes (1) the development ofmaterials co-designed with and tailored to facility staff whose primary language is alanguage other than English or who are from certain cultural affinity groups and (2) thedistribution of the developed materials by members of the language/cultural affinitygroups with peer advocacy activities (full intervention). The study is being conducted inWashington state and Georgia.Long-term care/residential facilities will be asked to furnish their staff booster rateat 4 timepoints: pre-intervention, and one month (timepoint 1), 3 months (timepoint 2),and 6 months (timepoint 3) post-intervention. Staff at participating long-term carefacilities will be invited to complete three online surveys at 3 timepoints:pre-intervention, 3 months post-intervention and 6 months post-intervention. Long-termcare facilities will be randomized to a trial arm following the pre-intervention datacollection.
Not Provided
Behavioral: Full Intervention
A small group of employees who work at facilities randomized to this arm will be invited
to develop tailored COVID-19 vaccination promotion materials in teams with other
long-term care staff sharing the same or similar language and/or cultural affinity. These
employees will also help promote these materials to all of the employees who work at
their facilities.
Other Name: Co-Design and Peer Advocacy
Other: Enhanced Usual Care
Employees who work at facilities randomized to this arm will see COVID-19 vaccine
promotion materials from the Centers for Disease Control and Prevention [CDC] or other
national organization.
Inclusion Criteria:
- Works at a participating long-term care facility that has more than 50 staff
members, has a staff COVID-19 booster vaccination rate of ≤60% as of December 1,
2021, and is located in Washington state or Georgia.
- 18 years or older
Exclusion Criteria:
- Does not work at an enrolled long-term care facility
- 17 years or younger
Kaiser Permanente Georgia Center for Research and Evaluation
Atlanta, Georgia, United States
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, United States
Clarissa Hsu, PhD, Principal Investigator
Kaiser Permanente